Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 182197, 14 pages
http://dx.doi.org/10.1155/2014/182197
Research Article

A Promising Approach to Provide Appropriate Colon Target Drug Delivery Systems of Vancomycin HCL: Pharmaceutical and Microbiological Studies

1Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia
2Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt
3Department of Pharmaceutics, National Organization for Drug Control and Research, Giza, Egypt
4Department of Microbiology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt

Received 29 September 2013; Revised 4 November 2013; Accepted 7 November 2013; Published 14 January 2014

Academic Editor: Fabio Sonvico

Copyright © 2014 Kadria A. Elkhodairy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. K. Philip, S. Dabas, and K. Pathak, “Optimized prodrug approach: a means for achieving enhanced anti-inflammatory potential in experimentally induced colitis,” Journal of Drug Targeting, vol. 17, no. 3, pp. 235–241, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. O. A. Odeku and J. T. Fell, “In-vitro evaluation of khaya and albizia gums as compression coatings for drug targeting to the colon,” Journal of Pharmacy and Pharmacology, vol. 57, no. 2, pp. 163–168, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. M. K. Chourasia and S. K. Jain, “Pharmaceutical approaches to colon targeted drug delivery systems,” Journal of Pharmacy and Pharmaceutical Sciences, vol. 6, no. 1, pp. 33–66, 2003. View at Google Scholar · View at Scopus
  4. A. Basit and J. Bloor, “Prespectives on colonic drug delivery: business briefing,” Pharmaceutical Technology, pp. 185–190, 2003. View at Google Scholar
  5. http://www.wikipedia.org/wiki/vancomycin.
  6. M. J. Kuehnert, D. Kruszon-Moran, H. A. Hill et al., “Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002,” Journal of Infectious Diseases, vol. 193, no. 2, pp. 172–179, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. H. F. Chambers, “Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications,” Clinical Microbiology Reviews, vol. 10, no. 4, pp. 781–791, 1997. View at Google Scholar · View at Scopus
  8. H. K. Tiwari and M. R. Sen, “Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India,” BMC Infectious Diseases, vol. 6, article 156, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. Clinical and Laboratory Standards Institute (CLSI), “Performance standards for antimicrobial susceptibility testing,” Twenty-First Informational Supplement. M100-S21, vol. 31, no. 1, 2011. View at Google Scholar
  10. P. Courvalin, “Vancomycin resistance in gram-positive Cocci,” Clinical Infectious Diseases, vol. 42, no. 1, pp. S25–S34, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Meziane-Cherif, F. A. Saul, C. Moubareck et al., “Molecular basis of vancomycin dependence in VanA-type Staphylococcus aureus VRSA-9,” Journal of Bacteriology, vol. 192, no. 20, pp. 5465–5471, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. Drugs A to Z > Va > Vancomycin, http://www.drugs.com.
  13. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=91c050cf-3b2d-48bc-7297-e8dc68225e5a, 2008.
  14. H. Maier, M. Anderson, C. Karl, K. Maqnuson, and R. L. Whistler, “Industrial Gums,” in Polysaccharides and their Derivatives, Academic Press, New York, NY, USA, 3rd edition, 1993. View at Google Scholar
  15. G. L. Simon and S. L. Gorbach, “Intestinal flora in health and disease,” Gastroenterology, vol. 86, no. 1, pp. 174–193, 1984. View at Google Scholar · View at Scopus
  16. G. T. Macfarlane, S. Hay, S. Macfarlane, and G. R. Gibson, “Effect of different carbohydrates on growth, polysaccharidase and glycosidase production by Bacteroides ovatus, in batch and continuous culture,” Journal of Applied Bacteriology, vol. 68, no. 2, pp. 179–187, 1990. View at Google Scholar · View at Scopus
  17. F. Bigucci, B. Luppi, L. Monaco, T. Cerchiara, and V. Zecchi, “Pectin-based microspheres for colon-specific delivery of vancomycin,” Journal of Pharmacy and Pharmacology, vol. 61, no. 1, pp. 41–46, 2009. View at Google Scholar
  18. F. Bigucci, B. Luppi, A. Musenga, V. Zecchi, and T. Cerchiara, “Chitosan salts coated with stearic acid as colon-specific delivery systems for vancomycin,” Drug Delivery, vol. 15, no. 5, pp. 289–293, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Bigucci, B. Luppi, T. Cerchiara et al., “Chitosan/pectin polyelectrolyte complexes: selection of suitable preparative conditions for colon-specific delivery of vancomycin,” European Journal of Pharmaceutical Sciences, vol. 35, no. 5, pp. 435–441, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Cerchiara, B. Luppi, F. Bigucci, M. Petrachi, I. Orienti, and V. Zecchi, “Controlled release of vancomycin from freeze-dried chitosan salts coated with different fatty acids by spray-drying,” Journal of Microencapsulation, vol. 20, no. 4, pp. 473–478, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. T. P. Hadjiioannou, G. D. Christian, and M. A. koupparis, “Quantitative calculations,” in Pharmaceutical Practices and Research, pp. 345–348, NY- VCH, New Dehli, India, 1993. View at Google Scholar
  22. R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri, and N. A. Peppas, “Mechanisms of solute release from porous hydrophilic polymers,” International Journal of Pharmaceutics, vol. 15, no. 1, pp. 25–35, 1983. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Siepmann and N. A. Peppas, “Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC),” Advanced Drug Delivery Reviews, vol. 48, no. 2-3, pp. 139–157, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. A. S. Izhar, M. S. Jagan, and R. Y. Madhusudan, “Modulating the release behavior and kinetic evaluation of diclofenac sodium from natural polymers,” International Journal of Chemical Technology and Research, vol. 2, no. 2, pp. 834–841, 2010. View at Google Scholar
  25. P. Apparao, J. V. Prabhakarreddy, J. Raju, and B. Shashidher, “Formulation and evaluation of gum based matrix tablets of Lamivudine,” Der Pharmacia Sinica, vol. 2, no. 3, pp. 176–192, 2011. View at Google Scholar
  26. Centers for Disease Control and Prevention, “Vancomycin-resistant Staphylococcus aureus,” MMWR Morbidity Mortality Weekly Report 53:322-3, New York, NY, USA, 2004. View at Google Scholar
  27. Clinical and Laboratory Standards Institute (CLSI), “Surveillance for methicillin-resistant Staphylococcus aureus: principles, practices, and challenges,” A Report X07-R, 2011. View at Google Scholar
  28. C. J. Fernandes, M. V. N. O'Sullivan, Y. Cai et al., “Agar dilution method for detection of inducible clindamycin resistance in Staphylococcus spp,” Journal of Clinical Microbiology, vol. 45, no. 12, pp. 4018–4020, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. National Committee for Clinical Laboratory Standards, Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline, NCCLS document M26-A, Wayne, Pa, USA, 1999.
  30. F. Lia, M. D. Weir, A. F. Fouad, and H. H. K. Xub, “Time-kill behaviour against eight bacterial species and cytotoxicity of antibacterial monomers,” Journal of Dentistry, vol. 41, no. 10, pp. 881–891, 2013. View at Publisher · View at Google Scholar
  31. M. M. Gupta and T. R. Saini, “Preformulation parameterscharacterization to design, development and formulation of vancomycin hydrochloride tablets for psudomembranous colitis,” International Journal of Pharmaceutical Research and Delivery, vol. 9, no. 1, pp. 1–7, 2009. View at Google Scholar
  32. B. Abrahamsson, M. Alpsten, B. Bake, A. Larsson, and J. Sjögren, “In vitro and in vivo erosion of two different hydrophilic gel matrix tablets,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 46, no. 1, pp. 69–75, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. W. Chien, “Novel Drug Delivery Systems,” in Fundamentals of Rate-Controlled Drug, Marcel Dekker, New York, NY, USA, 1992. View at Google Scholar
  34. B. M. Al-Taani and B. M. Tashtoush, “Effect of microenvironment pH of swellable and erodable buffered matrices on the release characteristics of diclofenac sodium,” AAPS Pharmaceutical Science Technology, vol. 4, no. 3, article E43, 2003. View at Google Scholar · View at Scopus
  35. M. Chaplin, Water Structure and Behavior: Guar Gum, South Bank University, London, UK, 2006.
  36. P. M. Husen, P. A. Kumar, S. V. Kulkarni, and R. B. Someshwara, “Design and evaluation of controlled release matrix tablets of Metoclopramide hydrochloride using hydrophilic polymers,” International Journal of Current Pharmaceutical Research, vol. 4, no. 3, pp. 64–69, 2012. View at Google Scholar
  37. A. M. Cerdeira, P. Goucha, and A. J. Almeida, “Hydroxypropyl methylcellulose phthalate beads containing a model non-steroid anti-inflammatory drug,” International Journal of Pharmaceutics, vol. 164, no. 1-2, pp. 147–154, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Singhal, H. Jain, V. Singhal, E. J. Elias, and A. Showkat, “Colon-targeted quercetin delivery using natural polymer to enhance its bioavailability,” Pharmacognosy Research, vol. 3, no. 1, pp. 35–39, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. A. B. Prasath, R. Sankaranand, S. Nantheeswaran et al., “Colon targeted drug delivery of propranolol hydro chloride by using different natural polymers,” International Journal of Research in Pharmaceutical Sciences, vol. 2, no. 3, pp. 353–358, 2011. View at Google Scholar · View at Scopus
  40. P. W. S. Heng, L. W. Chan, M. G. Easterbrook, and X. Li, “Investigation of the influence of mean HPMC particle size and number of polymer particles on the release of aspirin from swellable hydrophilic matrix tablets,” Journal of Controlled Release, vol. 76, no. 1-2, pp. 39–49, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Gafourian, A. Safari, K. Adibkia, F. Parviz, and A. Nokhodchi, “A drug release study from hydroxypropylmethylcellulose (HPMC) matrices using QSPR modeling,” Journal of Pharmaceutical Sciences, vol. 96, no. 12, pp. 3334–3351, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. D. B. Raju, S. M. M. K. Babu, and M. M. Varma, “Design development and evaluation of extended release tablets of Alfuzosin hydrochloride,” Journal of Chemistry and Pharmaceutical Research, vol. 2, no. 2, pp. 90–92, 2010. View at Google Scholar
  43. B. Nath, L. Nath, and P. Kumar, “Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations,” Acta Poloniae Pharmaceutica, vol. 68, no. 3, pp. 409–415, 2011. View at Google Scholar · View at Scopus